Takeda Pharmaceutical Co Ltd (TAK)
13.62
+0.06
(+0.41%)
USD |
NYSE |
Nov 15, 16:00
13.62
0.00 (0.00%)
After-Hours: 19:24
Takeda Pharmaceutical Market Cap: 43.20B for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 43.02B |
| November 13, 2024 | 42.99B |
| November 12, 2024 | 42.93B |
| November 11, 2024 | 43.28B |
| November 08, 2024 | 43.69B |
| November 07, 2024 | 43.94B |
| November 06, 2024 | 43.72B |
| November 05, 2024 | 45.08B |
| November 04, 2024 | 44.54B |
| November 01, 2024 | 44.26B |
| October 31, 2024 | 44.19B |
| October 30, 2024 | 44.04B |
| October 29, 2024 | 43.91B |
| October 28, 2024 | 43.12B |
| October 25, 2024 | 43.02B |
| October 24, 2024 | 43.75B |
| October 23, 2024 | 43.94B |
| October 22, 2024 | 44.80B |
| October 21, 2024 | 44.86B |
| October 18, 2024 | 45.43B |
| October 17, 2024 | 45.21B |
| October 16, 2024 | 44.64B |
| October 15, 2024 | 44.54B |
| October 14, 2024 | 45.46B |
| October 11, 2024 | 45.34B |
| Date | Value |
|---|---|
| October 10, 2024 | 45.37B |
| October 09, 2024 | 45.27B |
| October 08, 2024 | 45.34B |
| October 07, 2024 | 45.43B |
| October 04, 2024 | 45.75B |
| October 03, 2024 | 45.15B |
| October 02, 2024 | 45.40B |
| October 01, 2024 | 45.27B |
| September 30, 2024 | 45.08B |
| September 27, 2024 | 46.09B |
| September 26, 2024 | 46.44B |
| September 25, 2024 | 46.22B |
| September 24, 2024 | 46.91B |
| September 23, 2024 | 47.20B |
| September 20, 2024 | 46.91B |
| September 19, 2024 | 47.33B |
| September 18, 2024 | 46.98B |
| September 17, 2024 | 47.07B |
| September 16, 2024 | 46.91B |
| September 13, 2024 | 46.60B |
| September 12, 2024 | 46.98B |
| September 11, 2024 | 46.98B |
| September 10, 2024 | 47.20B |
| September 09, 2024 | 47.17B |
| September 06, 2024 | 46.95B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
38.61B
Minimum
Oct 19 2022
65.67B
Maximum
Nov 19 2019
49.31B
Average
47.82B
Median
Feb 16 2022
Market Cap Benchmarks
| HUTCHMED (China) Ltd | 2.862B |
| Astellas Pharma Inc | 19.15B |
| Nxera Pharma Co Ltd | 723.88M |
| PeptiDream Inc | 2.203B |
| Healios KK | 135.20M |
Market Cap Related Metrics
| PE Ratio | 22.54 |
| PS Ratio | 1.439 |
| PEG Ratio | 0.6240 |
| Price to Book Value | 0.8914 |
| Price to Free Cash Flow | 12.61 |
| Price | 13.62 |
| Earnings Yield | 4.44% |
| PEGY Ratio | 0.5548 |
| Operating PE Ratio | 13.84 |
| Normalized PE Ratio | 22.54 |